Literature DB >> 9461588

Modification of phosphatidylinositol 3-kinase SH2 domain binding properties by Abl- or Lck-mediated tyrosine phosphorylation at Tyr-688.

M von Willebrand1, S Williams, M Saxena, J Gilman, P Tailor, T Jascur, G P Amarante-Mendes, D R Green, T Mustelin.   

Abstract

In cells expressing the oncogenic Bcr-Abl tyrosine kinase, the regulatory p85 subunit of phosphatidylinositol 3-kinase is phosphorylated on tyrosine residues. We report that this phosphorylation event is readily catalyzed by the Abl and Lck protein-tyrosine kinases in vitro, by Bcr-Abl or a catalytically activated Lck-Y505F in co-transfected COS cells, and by endogenous kinases in transfected Jurkat T cells upon triggering of their T cell antigen receptor. Using these systems, we have mapped a major phosphorylation site to Tyr-688 in the C-terminal SH2 domain of p85. Tyrosine phosphorylation of p85 in vitro or in vivo was not associated with detectable change in the enzymatic activity of the phosphatidylinositol 3-kinase heterodimer, but correlated with a strong reduction in the binding of some, but not all, phosphoproteins to the SH2 domains of p85. This provides an additional candidate to the list of SH2 domains regulated by tyrosine phosphorylation and may explain why association of phosphatidylinositol 3-kinase with some cellular ligands is transient or of lower stoichiometry than anticipated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461588     DOI: 10.1074/jbc.273.7.3994

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo.

Authors:  Lazaros C Foukas; Caroline A Beeton; Jorgen Jensen; Wayne A Phillips; Peter R Shepherd
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Acetylcholine-dependent upregulation of TASK-1 channels in thalamic interneurons by a smooth muscle-like signalling pathway.

Authors:  Michael Leist; Susanne Rinné; Maia Datunashvili; Ania Aissaoui; Hans-Christian Pape; Niels Decher; Sven G Meuth; Thomas Budde
Journal:  J Physiol       Date:  2017-08-03       Impact factor: 5.182

3.  Membrane-binding/modification model of signaling protein activation and analysis of its control by cell morphology.

Authors:  Jason M Haugh
Journal:  Biophys J       Date:  2007-04-06       Impact factor: 4.033

4.  Computational models of tandem SRC homology 2 domain interactions and application to phosphoinositide 3-kinase.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  J Biol Chem       Date:  2008-01-20       Impact factor: 5.157

5.  A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival.

Authors:  Lindsey K Boroughs; Marc A Antonyak; Richard A Cerione
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

6.  Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.

Authors:  Souad Rahmouni; Torkel Vang; Andres Alonso; Scott Williams; Marianne van Stipdonk; Chiara Soncini; Michel Moutschen; Stephen P Schoenberger; Tomas Mustelin
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 7.  The multiple roles of phosphoinositide 3-kinase in mast cell biology.

Authors:  Mi-Sun Kim; Madeleine Rådinger; Alasdair M Gilfillan
Journal:  Trends Immunol       Date:  2008-09-03       Impact factor: 16.687

8.  Autophosphorylation of serine 608 in the p85 regulatory subunit of wild type or cancer-associated mutants of phosphoinositide 3-kinase does not affect its lipid kinase activity.

Authors:  Meredith J Layton; Mirette Saad; Nicole L Church; Richard B Pearson; Christina A Mitchell; Wayne A Phillips
Journal:  BMC Biochem       Date:  2012-12-27       Impact factor: 4.059

9.  Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.

Authors:  T Vang; K M Torgersen; V Sundvold; M Saxena; F O Levy; B S Skålhegg; V Hansson; T Mustelin; K Taskén
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  The triacylglycerol, hydroxytriolein, inhibits triple negative mammary breast cancer cell proliferation through a mechanism dependent on dihydroceramide and Akt.

Authors:  Francisca Guardiola-Serrano; Roberto Beteta-Göbel; Raquel Rodríguez-Lorca; Maitane Ibarguren; David J López; Silvia Terés; María Alonso-Sande; Mónica Higuera; Manuel Torres; Xavier Busquets; Pablo V Escribá
Journal:  Oncotarget       Date:  2019-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.